Table 1. Vimentin expression and patient characteristics.
Vimentin expression
|
|||
---|---|---|---|
Clinicopathological characteristic | High | Low | P -value |
Age | 64.4±8.6 | 61.1±9.9 | 0.037 |
Tumour size | 0.3±2.0 | 5.0±1.7 | 0.348 |
Gender | |||
Male | 32 | 48 | 0.670 |
Female | 27 | 35 | |
Tumour site | |||
Colon | 36 | 44 | 0.343 |
Rectum | 23 | 39 | |
Degree of differentiation | |||
Well | 27 | 45 | 0.321 |
Mod./poor | 32 | 38 | |
Depth of invasion | |||
mp | 5 | 8 | 0.812 |
ss | 54 | 75 | |
Lymph node metastasis | |||
Absent | 28 | 51 | 0.098 |
Present | 31 | 32 | |
No of lymph nodes involved | |||
0 | 28 | 51 | 0.167 |
1–3 | 20 | 24 | |
⩾4 | 11 | 8 | |
Lymphovascular invasion a | |||
Absent | 24 | 32 | 0.799 |
Present | 35 | 51 |
Well=well-differentiated adenocarcinoma, Mod.=moderately differentiated adenocarcinoma, Poor=poorly differentiated carcinoma (this category included five cases of poorly differentiated adenocarcinoma, five cases of mucinous carcinoma and one case of signet ring cell carcinoma), mp=muscularis propria; ss=subserosa.
Lymphatic invasion was determined by the presence of tumour cells in lymphatic ducts. Bold value is statistically significant (P<0.05).